MedPath
NMPA Approval

Fexofenadine Hydrochloride Tablets

国药准字HJ20210012

February 10, 2021

Drug Information

盐酸非索非那定片

艾利敏

片剂

180mg

化学药品

February 10, 2021

February 9, 2026

Company Information

Applicant Company

157 avenue Charles de Gaulle 92200 Neuilly Sur Seine, France

Manufacturing Company

30-36 AVENUE GUSTAVE EIFFEL, 37100 TOURS, FRANCE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸非索非那定片 - NMPA 批准文号 | MedPath